Eloxx Pharmaceuticals, Inc. Common Stock

ELOX XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

41M

Short interest (Jul 15)

0.3%

Net Short (Jul 27 ): -2.9%

Borrow Fee

42.27%

↓ 6.8%

Available Shares

200K

↓ 9.0%

Price Chart

Company Overview

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001035354

Asset Type: CS

Market Data

Market Cap: $41,029,589

Employees: 7

Status: Active

Short Interest

Current Borrow Fee 42.27%

Range: 42.13% - 45.25%

Available Shares 200K

Range: 55K - 200K

Recent Changes

Fee Change: ↓ 0.5%

Available Change: ↑ 64.5%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime